Saturday, November 28, 2015 Last update: 12:03 PM - Covering Large & Obscure Tech Companies Since 1996

Horizon Pharma to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2014

Companies mentioned in this article: Horizon Pharma

DEERFIELD, IL -- (Marketwired) -- 09/02/14 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Timothy P. Walbert, chairman, president and chief executive officer, will present in a fireside chat format discussion at the Morgan Stanley Global Healthcare Unplugged Conference 2014 on Monday, September 8, 2014 at 8:45 a.m. Eastern Time in New York, NY. Mr. Walbert will provide an overview of the Company and its corporate activities.

The presentation will be webcast live and may be accessed by visiting Horizon's website at A replay of the webcast will be available for 10 business days.

About Horizon Pharma

Horizon Pharma, Inc. (NASDAQ: HZNP) is a specialty pharmaceutical company focused on improving patients' lives by identifying, acquiring and commercializing differentiated products that address unmet medical needs. The company markets a portfolio of products in the areas of arthritis, pain and inflammatory diseases. The company's U.S. marketed products are VIMOVO® (naproxen/esomeprazole), DUEXIS® (ibuprofen/famotidine) and RAYOS® (prednisone) delayed-release tablets. The company has announced the acquisition of Vidara Therapeutics International Public Limited Company ("Vidara") through a reverse merger, which is expected to close in September. Upon the closing of the Vidara transaction, the company will add ACTIMMUNE® (interferon gamma-1b), an orphan product marketed for use in children and adults with chronic granulomatous disease and severe, malignant osteopetrosis, to its portfolio of U.S. marketed products. For more information, please visit


Robert F. Carey
Executive Vice President, Chief Business Officer
Email Contact